PerfuseCell Cronus A/S: Financial statements 2015
CVR: 31606810
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
PerfuseCell Cronus A/S (CVR 31606810) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 0 and a net result of DKK -180 compared with DKK -2,609 the year before. Equity in the 2015 report amounted to DKK 14,327. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK -180
- Equity
- DKK 14,327
- Total Assets
- DKK 14,327
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | 0 | 0 | -180 | 14 t. | - |
| 2014 | 0 | 0 | -3 t. | 15 t. | - |
| 2013 | 3 t. | 3 t. | -631 | 17 t. | - |
| 2012 | - | -45 t. | -45 t. | 18 t. | - |
Official annual report
How creditworthy is PerfuseCell Cronus A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
As of April 1, 2015, Erik Johansen has left the board of directors of PerfuseCell Cronus A/S.
As of April 1, 2015, Per Stobbe is registered as adm. dir. of PerfuseCell Cronus A/S.
As of April 1, 2015, Niels Johansen has stepped down as director of PerfuseCell Cronus A/S.
On April 1, 2015, the company changed its name from HELIOPOWER A/S to PumpCell A/S.
PerfuseCell Cronus A/S has published its annual report for 2014. Revenue came to DKK 0, and the net result was DKK -2,609.
About PerfuseCell Cronus A/S
PerfuseCell Cronus A/S is a Danish company of the type Aktieselskab based in Herlev, founded in 2008. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named PerfuseCell A/S and PumpCell A/S. The management consists of Per Stobbe. The board consists of August Kisling Stobbe, Flemming Petersen and Per Stobbe. The company is owned by Stobbe GmbH. In 2025, the company reported a gross profit of DKK 20,467 and a net result of DKK 23,973 compared with DKK 2,216 the year before. Equity in the 2025 report amounted to DKK 1,070,836.